Oncothyreon HomeContactSite MapGlossary
Investors
 
Stock Information
NASDAQ: ONTY
$4.70   + 0.04
Nov 20, 2009
4:00 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
Financial Information
Regulatory Filings

Filing Description Date Filed Size Sorted Ascending  
F-10 form f-10 Apr 23, 2002 0.0 KB  
424B3 prospectus filed pursuant to rule 424 Feb 12, 2002 0.0 KB  
6-K report of foreign issuer Feb 12, 2002 0.0 KB  
6-K report of foreign issuer Mar 25, 2002 0.0 KB  
424B3 prospectus filed pursuant to rule 424 Jun 17, 2002 0.0 KB  
F-10/A form f-10/a Apr 30, 2002 0.0 KB  
6-K report of foreign issuer Apr 22, 2002 0.0 KB  
6-K report of foreign issuer May 6, 2002 0.0 KB  
6-K report of foreign issuer Jun 18, 2002 0.0 KB  
40-F form 40-f May 17, 2002 0.0 KB  
F-X form f-x Apr 23, 2002 0.0 KB  
EFFECT effectiveness order Apr 9, 2008 0.0 KB  
EFFECT effectiveness order Oct 31, 2007 0.0 KB  
EFFECT effectiveness order Nov 7, 2007 0.0 KB  
EFFECT effectiveness order Aug 12, 2008 0.0 KB  
424B3 prospectus filed pursuant to rule 424 Aug 29, 2002 23.5 KB Add to Briefcase
424B3 prospectus filed pursuant to rule 424 Aug 5, 2002 23.9 KB Add to Briefcase
424B3 prospectus filed pursuant to rule 424 Feb 7, 2003 24.4 KB Add to Briefcase
424B3 prospectus filed pursuant to rule 424 Apr 9, 2003 24.5 KB Add to Briefcase
424B3 prospectus filed pursuant to rule 424 Sep 12, 2002 24.5 KB Add to Briefcase
Showing 1-20 of 330 Page: 1 2 3 ... 17  Next 20
Add to Briefcase = add filing to Briefcase

return to top ^

About Oncothyreon | Pipeline | Clinical Trials | Business Development | Investors | News & Events